122 related articles for article (PubMed ID: 12565177)
1. The minimum LOH region defined on chromosome 17p13.3 in human hepatocellular carcinoma with gene content analysis.
Zhao X; He M; Wan D; Ye Y; He Y; Han L; Guo M; Huang Y; Qin W; Wang MW; Chong W; Chen J; Zhang L; Yang N; Xu B; Wu M; Zuo L; Gu J
Cancer Lett; 2003 Feb; 190(2):221-32. PubMed ID: 12565177
[TBL] [Abstract][Full Text] [Related]
2. [Analysis on loss of heterozygosity of chromosome 17p13.3 in hepatocellular carcinoma and construction of genomic contig in the deleted region].
Zhao X; Wan D; Jiang H
Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):377-80. PubMed ID: 11778272
[TBL] [Abstract][Full Text] [Related]
3. A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma.
Zhao X; Li J; He Y; Lan F; Fu L; Guo J; Zhao R; Ye Y; He M; Chong W; Chen J; Zhang L; Yang N; Xu B; Wu M; Wan D; Gu J
Cancer Res; 2001 Oct; 61(20):7383-7. PubMed ID: 11606366
[TBL] [Abstract][Full Text] [Related]
4. Evidence for another tumor suppressor gene at 17p13.3 distal to TP53 in hepatocellular carcinoma.
Guan XY; Sham JS; Tai LS; Fang Y; Li H; Liang Q
Cancer Genet Cytogenet; 2003 Jan; 140(1):45-8. PubMed ID: 12550757
[TBL] [Abstract][Full Text] [Related]
5. Genetic aberration in primary hepatocellular carcinoma: correlation between p53 gene mutation and loss-of-heterozygosity on chromosome 16q21-q23 and 9p21-p23.
Wang G; Huang CH; Zhao Y; Cai L; Wang Y; Xiu SJ; Jiang ZW; Yang S; Zhao T; Huang W; Gu JR
Cell Res; 2000 Dec; 10(4):311-23. PubMed ID: 11191353
[TBL] [Abstract][Full Text] [Related]
6. A 2-Mb sequence-ready contig map and a novel immunoglobulin superfamily gene IGSF4 in the LOH region of chromosome 11q23.2.
Gomyo H; Arai Y; Tanigami A; Murakami Y; Hattori M; Hosoda F; Arai K; Aikawa Y; Tsuda H; Hirohashi S; Asakawa S; Shimizu N; Soeda E; Sakaki Y; Ohki M
Genomics; 1999 Dec; 62(2):139-46. PubMed ID: 10610705
[TBL] [Abstract][Full Text] [Related]
7. Expression map of human chromosome region 17p13.3, spanning the RP13 dominant retinitis pigmentosa locus, the Miller-Dieker lissencephaly syndrome (MDLS) region, and a putative tumour suppressor locus.
McHale JC; McKie AB; Tarttelin EE; Inglehearn CF
Cytogenet Cell Genet; 2000; 88(3-4):225-9. PubMed ID: 10828595
[TBL] [Abstract][Full Text] [Related]
8. [Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder].
Zheng S; Zhang J; Di X; Xiao Z; Wang D; Li C; He Z; Han N; Guo S; Cheng S; Gao Y
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):161-3. PubMed ID: 11953150
[TBL] [Abstract][Full Text] [Related]
9. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.
Suzuki K; Hirooka Y; Tsujitani S; Yamane Y; Ikeguchi M; Kaibara N
Anticancer Res; 2000; 20(2B):1257-62. PubMed ID: 10810431
[TBL] [Abstract][Full Text] [Related]
10. [Loss of heterozygosity on chromosomes 17 and 16 in primary hepatocellular carcinomas].
Shao J; Li X; Liu Z
Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):428-30. PubMed ID: 11715437
[TBL] [Abstract][Full Text] [Related]
11. Cloning and characterization of a novel gene (C17orf25) from the deletion region on chromosome 17p13.3 in hepatocelular carcinoma.
Qin WX; Wan F; Sun FY; Zhang PP; Han LW; Huang Y; Jiang HQ; Zhao XT; He M; Ye Y; Cong WM; Wu MC; Zhang LS; Yang NW; Gu JR
Cell Res; 2001 Sep; 11(3):209-16. PubMed ID: 11642406
[TBL] [Abstract][Full Text] [Related]
12. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.
Konishi H; Sugiyama M; Mizuno K; Saito H; Yatabe Y; Takahashi T; Osada H; Takahashi T
Oncogene; 2003 Mar; 22(12):1892-905. PubMed ID: 12660825
[TBL] [Abstract][Full Text] [Related]
13. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
[TBL] [Abstract][Full Text] [Related]
14. Sequence-ready contig for the 1.4-cM ductal carcinoma in situ loss of heterozygosity region on chromosome 8p22-p23.
Wang JC; Radford DM; Holt MS; Helms C; Goate A; Brandt W; Parik M; Phillips NJ; DeSchryver K; Schuh ME; Fair KL; Ritter JH; Marshall P; Donis-Keller H
Genomics; 1999 Aug; 60(1):1-11. PubMed ID: 10458905
[TBL] [Abstract][Full Text] [Related]
15. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.
Nishida N; Fukuda Y; Kokuryu H; Toguchida J; Yandell DW; Ikenega M; Imura H; Ishizaki K
Cancer Res; 1993 Jan; 53(2):368-72. PubMed ID: 8093350
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity analysis of chromosome 17p13.1-13.3 and its correlation with clinical outcome in medulloblastomas.
Jung HL; Wang KC; Kim SK; Sung KW; Koo HH; Shin HY; Ahn HS; Shin HJ; Cho BK
J Neurooncol; 2004; 67(1-2):41-6. PubMed ID: 15072446
[TBL] [Abstract][Full Text] [Related]
18. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity on chromosome 10q22-10q23 and 22q11.2-22q12.1 and p53 gene in primary hepatocellular carcinoma.
Zhu GN; Zuo L; Zhou Q; Zhang SM; Zhu HQ; Gui SY; Wang Y
World J Gastroenterol; 2004 Jul; 10(13):1975-8. PubMed ID: 15222050
[TBL] [Abstract][Full Text] [Related]
20. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
